Dicer is an enzyme that generates microRNA (miRNA), which are small, noncoding RNA that function as important regulators of gene and protein expression. For exploration of the functional roles of miRNA in glomerular biology, Dicer was inactivated selectively in mouse podocytes. Mutant mice developed proteinuria 4 to 5 weeks after birth and died several weeks later, presumably from kidney failure. Multiple abnormalities were observed in glomeruli of mutant mice, including foot process effacement, irregular and split areas of the glomerular basement membrane, podocyte apoptosis and depletion, mesangial expansion, capillary dilation, and glomerulosclerosis. Gene profiling revealed upregulation of 190 genes in glomeruli isolated from mutant mice at the onset of proteinuria compared with control littermates. Target sequences for 16 miRNA were significantly enriched in the 3Ј-untranslated regions of the 190 upregulated genes. Further suggesting validity of the in silico analysis, six of the eight top-candidate miRNA were identified in miRNA libraries generated from podocyte cultures; these included four members of the mir-30 miRNA family, which are known to degrade target transcripts directly. Among 15 upregulated target genes of the mir-30 miRNA, four genes known to be expressed and/or functional in podocytes were identified, including receptor for advanced glycation end product, vimentin, heat-shock protein 20, and immediate early response 3. Receptor for advanced glycation end product and immediate early response 3 are known to mediate podocyte apoptosis, whereas vimentin and heat-shock protein-20 are involved in cytoskeletal structure. Taken together, these results provide a knowledge base for ongoing investigations to validate functional roles for the mir-30 miRNA family in podocyte homeostasis and podocytopathies.
The importance of miRNA in development and tissue homeostasis is now well documented. Abrogating Dicer to prevent production of functional miRNA in mice resulted in embryonic lethality at approximately embryonic day 7.5. 7 Studies of conditional ablation of Dicer in immune cells, 8, 9 developing oocytes, 10, 11 limb buds, 12 Purkinje cells, 13 chondrocytes, 14 and heart 15 all have suggested critical roles of miRNA in multiple biologic processes in those target cells, including proliferation, differentiation, and maintenance of cell structure and function. In addition to Dicer-deficient models of global miRNA inactivation, single miRNA have been shown to be required in regulating a variety of cellular processes, for example, inactivation of miR-208 and miR-155 in mice has revealed their roles in mediating cardiomyocyte hypertrophy in response to stress 16 and in regulating T helper cell differentiation and the germinal center reaction, 17, 18 respectively. Besides, miRNA are implicated in other biologic processes. 19 -22 Whereas recent observations suggested a role for mouse miR-192 in glomerular TGF-␤ and hyperglycemia-induced expression of collagen I ␣2 in glomeruli, 23 the roles of miRNA in kidney remain largely unknown.
Here, we report functional, morphologic, and molecular alterations induced by conditional inactivation of Dicer selectively in podocytes of mice. The mutant mice manifest a sequelae of podocyte and glomerular abnormalities, including foot process (FP) effacement, glomerular basement membrane (GBM) alterations, proteinuria, podocyte apoptosis, podocyte depletion, mesangial expansion, and glomerulosclerosis consistent with the podocyte depletion paradigm of progressive glomerulosclerosis. 24, 25 Thus, miRNA control expression of genes and gene products that are essential for structural homeostasis and survival of mature podocytes in mice. The identification and characterization of specific miRNA and their target genes that are critical for podocyte maintenance are ongoing and are expected to produce novel insights into mechanisms of glomerular diseases.
RESULTS

NPHS2-Cre Efficiently Deletes Dicer and Eliminates miRNA
To confirm that podocin promoter-controlled NPHS2-Cre transgene efficiently deleted loxP-flanked sequences in podocytes, we crossed Nphs2-Cre transgenic and Rosa26 reporter mice followed by ␤-gal staining of kidney sections. NPHS2-Cre mediated successful recombination at the Rosa26 reporter locus as demonstrated by positive ␤-gal staining in glomeruli of Rosa26/ϩ:NPHS2-Cre mice at 2 wk of age ( Figure 1, A and B) . A schematic representation depicts the Dicer alleles before and after Cre-mediated recombination ( Figure 1C ). PCR of genomic DNA obtained from isolated glomeruli confirmed Cre-mediated recombination of Dicer alleles in podocytes of glomeruli from conditional knockout (mutant) mice (Dicer F/F :NPHS2-Cre) with and without proteinuria ( Figure 1D ). To confirm that Dicer deletion resulted in loss of miRNA in podocytes, we examined the abundance of mature form of miR-30d and miR-23b, two miRNA that are known to be expressed in podocytes . (E) Histogram shows the abundances of miR-30d and miR-23b in mutant mice without (ϪPU) and with (ϩPU) proteinuria relative to that in control mice. The bars represent average Ϯ SD (n ϭ 3). (F) Histogram shows the abundances of premiR-30a, 30c-2, and 30d in mutant without (ϪPU) and with (ϩPU) proteinuria relative to that in control mice. Bars represent average Ϯ SD (n ϭ 3).
(smiRNAdb [http://www.mirz.unibas.ch/smiRNAdb/]). Compared with control (Dicer F/ϩ :NPHS2-Cre), levels of both miRNA were significantly reduced in glomeruli of mutant mice and the miRNA reduction was inversely correlated with the absence or presence of proteinuria ( Figure  1E ). Residual levels of miRNA present in glomeruli of mutant mice were likely due to variation of efficiency of Dicer deletion in different podocytes/glomeruli and/or to expression of the miRNA in endocapillary cells. To demonstrate further that Dicer was inactive in precursor miRNA processing, we conducted quantitative real-time PCR to examine whether precursor miR-30a, 30c-2, and 30d accumulated in mutant podocytes. The result showed the abundances of these precursor miRNA in mutant podocytes were indeed significantly higher than that in control podocytes ( Figure 1F ). The distribution of observed genotype frequencies among offspring of heterozygotic crosses was consistent with the expected genotype distribution on the basis of Mendelian ratio (data not shown). The mutant mice were indistinguishable from wild-type littermates within the first 5 wk of life, suggesting that Dicer deletion driven by NPHS2-Cre did not cause embryonic lethality or overt postnatal developmental phenotypes.
Progress of proteinuria was monitored periodically in cohorts of mutant (Dicer F/F :NPHS2-Cre) and control (Dicer F/ϩ : NPHS2-Cre, Dicer F/F , and Dicer F/ϩ ) littermate mice by urine dipsticks. The average age at proteinuria onset was 4.7 Ϯ 2.0 wk (SD), ranging from approximately 2 wk to 10 mo of age (n ϭ 50). Once proteinuria was detectable, it progressed subsequently to high-grade proteinuria and the mice died within several weeks. Proteinuria progression was associated with weight loss and runted and pale appearance followed by death. The average lifespan of mutant mice was 7.89 Ϯ 1.97 wk (SD), ranging from 4 wk to 1 yr (n ϭ 26). There was no gender dimorphism in lifespan and any of the observed phenotype manifestations (15 males, 11 females; data not shown). Mice heterozygous for Dicer deletion in podocytes (Dicer F/ϩ : NPHS2-Cre) were indistinguishable from wild-type mice with regard to growth, urinary protein excretion, appearance, and lifespan (n ϭ 13).
Dicer Mutant Mice Developed Progressive Glomerulosclerosis and Tubulointerstitial Fibrosis
Kidneys of mutant mice (Dicer F/F :NPHS2-Cre) with severe proteinuria appeared smaller, paler, and denser when compared with control kidneys (Figure 2A ). Histopathology of kidney in mutant mice was assessed by examination of periodic acid-Schiff-stained sections. Low-power microscopy revealed protein casts in tubular lumens of degenerated nephrons, the frequency of which was proportional to the level of proteinuria determined by dipstick ( Figure 2B ). In glomeruli, progressive sclerosis was observed with increased extracellular matrix deposition, mesangial expansion, reduced cellularity, and capillary dilations (Figure 2, D through F) .
Ultrastructural analysis of glomeruli by electron microscopy demonstrated normal podocyte FP and GBM morphology in mutant mice without proteinuria (n ϭ 4) and control mice (n ϭ 5). In contrast, FP effacement, splitting of GBM, and irregular GBM were observed in glomeruli of mice with pro- BASIC RESEARCH www.jasn.org teinuria ( Figure 2 , G and H). FP effacement was first detectable in glomeruli of mutant mice with new onset of proteinuria, whereas GBM alterations were observed in mutant mice with advanced proteinuria. These results indicate that FP effacement was the earliest morphologic defect in mutant glomeruli.
Immunofluorescence labeling for podocyte differentiation markers synaptopodin and podocin expression was comparable in control and mutant glomeruli without proteinuria, but both markers were reduced in mutant mice with onset of proteinuria ( Figure 3 ). In contrast, components of GBM, including collagen IV, laminin, and nidogen/entactin, 26 -30 were indistinguishable between control and mutant mice, irrespective of the absence or presence of proteinuria (Supplemental Figure  1S ). Together, these observations suggest that podocyte dedifferentiation coincides with onset of FP effacement and proteinuria in mutant mice without detectable difference of GBM components.
Dicer Deletion in Podocyte Leads to Podocyte Apoptosis and Depletion
Podocyte apoptosis has been identified as one cause of podocyte depletion in experimental kidney diseases in mice. [31] [32] [33] Rates of apoptotic podocytes were determined by triple-immunofluorescence labeling including terminal deoxynucleotidyl transferase-mediated digoxigenin-deoxyuridine nick-end labeling (TUNEL) assay, WT1, and DAPI ( Figure 4 , A through D). Apoptotic podocytes were rare or absent in glomerular sections of control mice or mutant mice without proteinuria, respectively. In contrast, rates of apoptotic podocytes per 100 glomerular sections were increased in mutant mice with lowgrade proteinuria or high-grade proteinuria, respectively (Figure 4E ). In addition, WT1-positive cells were detectable in tubular lumens of mutant mice with proteinuria but not in control or mutant mice without proteinuria (data not shown). Rates of apoptosis per 100 glomerular sections of WT1-negative cells were also increased in mutant mice with low-grade and high-grade proteinuria, respectively. Apoptosis was detectable in tubular epithelial cells, in particular in mutant mice with high-grade proteinuria (data not shown). Taken together, these results demonstrate that apoptosis of podocytes was closely correlated with the degree of proteinuria in Dicer mutant mice.
WT1 immunostaining was performed to examine whether podocyte number was altered in mutant mice. WT1 and DAPI double-positive cells were counted as podocytes as described previously. 32 Five-week-old mutant mice were divided into three groups according to severities of proteinuria: (1) None, (2) low-grade proteinuria (approximately 100 g/ml), and (3) high-grade proteinuria (Ն300 g/ml). Podocyte counts per glomerular section were comparable between mutant mice without proteinuria (n ϭ 4) and age-matched control mice (n ϭ 11; Figure 4F ). In contrast, podocyte counts per glomerular section were significantly decreased (P Ͻ 0.01) in mutant mice with low-grade proteinuria (n ϭ 5) and in mutant mice with high-grade proteinuria (n ϭ 5; Figure 4F ).
Global Gene Expression Profiling of Glomeruli of Mutant Mice
Inactivation of Dicer/miRNA in podocytes was expected to alter expression of specific miRNA target genes. To identify these genes, we performed microarray analyses on isolated glomeruli from three groups of 4-to 5-wk-old mice: (1) Control (Dicer F/ϩ :NPHS2-Cre, 5 mice), (2) mutant without proteinuria (5 mice), and (3) mutant at proteinuria onset (10 mice with proteinuria: 100 to 300 mg/L). Kidneys of mutant mice with new-onset proteinuria were characterized by tubular protein casts and evidence of segmental glomerulosclerosis and mesangial expansion in a few glomeruli, whereas the majority of glomeruli appeared normal by light microscopy. The results from microarray analyses showed that gene expression profiles of control and mutant mice without proteinuria were indistinguishable (data not shown). In contrast, 190 transcripts were significantly upregulated (q Ͻ 10%) in mutant mice with new-onset proteinuria compared with control (Supplemental Table 1S ). Among those genes, 68 were Ͼ1.5-fold elevated (Table 1) . A total of 121 genes were downregulated Ͼ1.5-fold (Supplemental Table 2S ).
We selected 14 of the 68 upregulated genes for validation of microarray measurements by quantitative real-time PCR. The Figure 3 . Synaptopodin and podocin expressions both were downregulated in podocytes of mutant mice with proteinuria (ϩPU). Different degrees of synaptopodin and podocin downregulations are shown in the middle panels (milder) and right panels (more severe). Magnification, ϫ40. upregulation of 13 of 14 genes was confirmed (Supplemental Figure 2S ). To confirm that the upregulation of gene expression was specifically in podocytes but not in other types of glomerular cells, we conducted immunofluorescence staining using available antibody against SM22␣ (Transgelin), a smooth muscle differentiation marker, and found that SM22␣ signal co-localized with synaptopodin (Supplemental Figure  3S) , indicating that the upregulation of SM22␣ was observed in podocytes of Dicer mutant mice with proteinuria. miRNA have been shown to degrade transcripts directly, resulting in negative regulation of steady-state mRNA levels. Thus, we hypothesized that genes with increased mRNA levels in mutant glomeruli may be direct targets for miRNA-mediated RNA degradation.
If some of the 190 upregulated transcripts of mutant podocytes are indeed miRNA degradation targets, then select miRNA target sequences would be expected to be overrepresented in the 3Ј untranslated regions (UTR) of the 190 transcripts. To examine this hypothesis, we used miRBase (http:// microrna.sanger.ac.uk) to search for miRNA target sequences in the 3Ј UTR of the 190 transcripts, and we found target sequences for 294 miRNA. The target sequence number of individual miRNA ranges from 1 to 19. Next, we performed permutation analyses on the occurrence of miRNA-target gene pairs to determine eight miRNA whose target sequences were significantly overrepresented (false discovery rate Ͻ5%) in the 190 upregulated transcripts ( Table 2 ). Among them, six were previously shown to be represented in miRNA library cloning from podocyte culture according to smiRNAdb (http://www. mirz.unibas.ch/smiRNAdb/). These included miR-28; miR34a; and four members of the miR-30 family, miR-30c-1, miR30b, miR-30d, and miR-30c-2. Among 68 upregulated genes with Ͼ1.5-fold change, 15 contained miR-30 family target sequences, including 0610010O12Rik, Ager (receptor for advanced glycation end products [RAGE]), Aplp1, Chst12, Gabrb1, Gclc, Hspb6, Ier3, Ifi30, Mthfd1l, Npepl1, Scel, Sulf2, Tnfrsf12a, Tspan4, and Vim (Supplemental Table 4S ). The miR-30 family members fulfilled all criteria for candidate miRNA. First, miR-30d was regulated in mutant glomeruli. Second, all four miR-30 miRNA are normally present in podocytes. Third, miR-30 miRNA are known RNA target-degrading miRNA. Fourth, miR-30 target sequences were highly enriched in upregulated genes in mutant glomeruli.
DISCUSSION
Mice mutant for Dicer in podocytes manifested variable expression of progressive proteinuria, structural glomerular defects and glomerulosclerosis consistent with the podocyte depletion paradigm, 24, 25 and tubulointerstitial fibrosis, demonstrating that miRNA exert essential genomic controls in podocytes. In an attempt to delineate the temporal sequence of the observed endophenotypes, we obtained evidence for podocyte dedifferentiation and FP effacement with GBM defects as the earliest detectable defects, followed by podocyte apoptosis, podocyte depletion, mesangial expansion, and segmental or global glomerulosclerosis. The age of onset and the extent of the observed defects were highly variable among mutant mice. This is likely attributable to variation in expression of transgenic Cre recombinase and Cre-dependent inactivation of Di- (1) control mice (n ϭ 9), one apoptotic podocyte found in 930 glomeruli examined; (2) mutant mice without proteinuria (Ϫ; n ϭ 4), no apoptotic podocyte in 379 glomeruli; (3) mutant mice with low-grade proteinuria (ϩ; n ϭ 6), three apoptotic podocytes in 590 glomeruli; (4) mutant mice with high-grade proteinuria (ϩϩ; n ϭ 7), 19 apoptotic podocytes in 874 glomeruli. (F) Podocyte number among four groups of mice as described in E shows podocyte numbers of mutant mice with proteinuria were reduced significantly. **P Ͻ 0.01. cer in podocytes in different glomeruli within an individual mouse and/or between different mice, as has been previously observed with the NPHS2-Cre transgenic model. 34 Interestingly, histologic and ultrastructural glomerular defects detectable in all mutant mice were coincident only with the onset and progression of proteinuria but not before proteinuria onset.
BASIC RESEARCH
In an unbiased approach to narrow the spectrum of molecular targets and cognate miRNA responsible for these defects, microarray analysis of glomerular gene expression profiles combined with in silico interrogation of genes with significant upregulation in mutant glomeruli identified candidate molecular mechanisms that may underlie the observed defects. The validity of our applied microarray and in silico approach to identify target-degrading miRNA for which Dicer deficiencyinduced loss of expression would be expected to result directly in increased expression of their respective target transcripts is supported by the following observations. First, six of the eight most significant candidate target-degrading miRNA are known to be present in podocytes, on the basis of limited sequencing information available in the smiRNAdb database (http://www.mirz.unibas.ch/smiRNAdb/), on miRNA libraries established from murine podocytes. Second, the identification of four known target mRNA-degrading miRNA of the miR-30 family, 35 all of which are expressed in podocytes, among the six most significant candidate podocyte miRNA is highly significant. For example, the observed frequency of hits among the 190 upregulated genes for miR-30 family miRNA indicated between 12 and 19 targets per miR-30 miRNA, compared with the expected frequency of five hits for random miRNA among the 190 upregulated transcripts. Moreover, only a few target-degrading miRNA have been identified (let7b, 36,37 miR-125b, 36 miR-1, 38 miR-124, 38 miR-122, 39 miR-16, 40 miR-98, 41 and miR-106b 42 ) to date in addition to the miR-30 family.
Among the list of 15 target genes of the mir-30 family in our study, several are known to be expressed in injured podocytes in experimental models and human kidney disease and have functional roles in apoptosis. For example, RAGE is barely detectable in podocytes in normal control mice but is strongly expressed in the streptozotocin murine models of diabetic kidney disease and of adriamycin-induced nondiabetic podocyte injury associated with proteinuria and glomerulosclerosis. 43, 44 Furthermore, RAGE is increased in podocytes of patients with diabetic nephropathy and several nondiabetic glomerular diseases. 45 Intriguingly, the known RAGE ligand S100 calciumbinding protein A6 (calcyclin) was among the top 20 upregulated genes in glomeruli of mutant mice with proteinuria (see Table 1 ). S100A6 binding with RAGE is known to induce apoptosis in epithelial cells through activation of Jun N-terminal kinase. 46 Thus, aberrant coincident upregulation of RAGE and its proapoptotic cognate ligand S100A6 may be caused by loss of podocyte mmu-mir-30b and possibly mmu-mir-431, respectively, and may directly contribute to podocyte injury and/or podocyte apoptosis observed in proteinuric mutant mice. The Ier3 is a predicted target of both mmu-mir-30c and mmu-mir-431. Ier3 also functions as positive regulator of apoptosis in keratinocytes 47 and has been identified in renal cDNA libraries as protein that interacts with modulators of apoptosis. 48 Podocyte apoptosis is an early glomerular manifestation leading to podocyte depletion in TGF-␤1 transgenic mice and CD2AP Ϫ/Ϫ and diabetic mouse models with albuminuria and glomerulosclerosis. [31] [32] [33] Observations in this study provide a rationale for a role of select miRNA-target gene pairs, such as miR-30 and miR-431 and RAGE and S100A6, in progressive glomerular disease.
Podocytes possess major processes containing microtubules and intermediate filaments with vimentin, and FP con- taining actin filaments as core cytoskeletal elements. 49 Heatshock protein 20 (Hsp20) and the intermediate filament protein vimentin both are shared targets of mmu-mir-30c-1 and 30c-2 and interact with cytoskeletal components. The intermediate filament vimentin is upregulated in podocytes of nephrotic glomeruli in puromycin aminonucleoside model in rat. 50 Hsp20 binds to actin in vitro and in vivo, and the association with filamentous actin is dependent on the phosphorylation state of Hsp20. 51 Interestingly, phosphorylated Hsp20 has a direct role in smooth muscle contractility and relaxation. 52 In addition, Tagln (SM22␣ and transgelin) is an actin cross-linking protein. 53, 54 The de novo expression of SM22␣ in podocytes of mutant glomeruli observed in our studies may disrupt the integrity of the actin cytoskeleton in podocytes and lead to FP effacement. In addition, Plod2 (lysyl hydroxylase 2), 55 is one of the three lysyl hydroxylases that mediate lysine hydroxylation of collagens, including collagen IV, which is essential for their proper assembly and cross-linking of collagen fibrils. 56 Upregulation of lysyl hydroxylase 2 may therefore underlie alterations of the collagen IV network and thus GBM defects in Dicer mutant mice. Pathway enrichment analysis based on gene expression data identified activation of integrin signaling as top pathway, consistent with the observed disruption of podocyte adhesion to GBM and GBM alterations. Integrin ␣-3 (Itga3) is the major ␣ subunit of ␤1 integrin receptors expressed by podocytes, and podocytes in kidneys of integrin ␣-3 knockout (Itga3 Ϫ/Ϫ ) mice are unable to maintain normal podocyte structure, including the elaboration of mature FP along the GBM. 57 Indeed, Itga3 mRNA was increased in mutant mice, consistent with integrin signaling activation. Functional validation of the discussed candidate miR-30 -target gene pairs requires an expansive experimental approach and is ongoing in our laboratory.
In conclusion, our results demonstrate that miRNA are important genomic regulators of molecular podocyte homeostasis. Disruption of miRNA-controlled gene networks results in progressive proteinuria and glomerulosclerosis. These findings warrant further studies to examine whether the dysregulation of miRNA-controlled gene networks may contribute to the pathogenesis of glomerular diseases. The identification of candidate miRNA-target gene pairs in our study may provide a starting point for further study to validate their role in glomerular diseases.
CONCISE METHODS
Mouse Strain
The use of the mice in this study adhered to the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The mouse line carrying a Dicer allele with two lox P sites that flank RNase III domain was created as described previously. 8 NPHS2-Cre was a gift from Dr. Holzman. 34 Rosa26 reporter mice were purchased from Jackson Laboratory (Bar Harbor, ME).
Antibodies
The antibodies used in this study were as follows: WT1 (Santa Cruz Biotechnology, Santa Cruz, CA), SM22␣ (Abcam, Cambridge, MA), laminin (Sigma, St. Louis, MO), entactin/nidogen (Chemicon Int., Temecula, CA), collagen IV (Southern Biotech, Birmingham, AL), and podocin (Santa Cruz, Santa Cruz, CA). Monoclonal synaptopodin antibody was prepared from hybridoma cells. Fluor-conjugated second antibodies, Alexa Fluor 488 goat anti-rabbit IgG (HϩL) and Alexa Fluor 568 goat anti-mouse Ig G1, both were purchased from Invitrogen (Carlsbad, CA).
␤-Galactosidase Staining of Kidney
The kidneys were excised from the mice, imbedded in OCT and snapfrozen. Five-micrometer sections were cut and stained for the expression of ␤-galactosidase using ␤-galactosidase Staining Kit (Specialty Media, Phillipsburg, NJ) following the manufacturer's instructions.
PCR for Genotyping
PCR to detect the deletion product in the podocytes was conducted using the primers D1 (5Ј-AGTAATGTGAGCAATAGTCCCAG-3Ј) and D3 (5Ј-CTGGTGGCTTGAGGACAAGAC-3Ј), which locate outside the loxP floxed region. PCR reaction was performed with standard protocol using TaqDNA polymerase (Invitrogen). The thermal cycling condition was 94°C for 2 min, followed by 35 cycles of 94°C for 15 s, 57°C for 15 s, and 72°C for 30 s. The predicted size of the PCR product derived from the allele undergone deletion is 309 bp.
Proteinuria Measurement
Strips of Albustix (Bayer Corp., Mishawaka, IN) were used to measure the proteinuria of mice at approximately 6 p.m. on the day of measurement.
Histology
Mice were perfused with 4% paraformaldehyde followed by 18% sucrose PBS solution. The kidneys were cut into two halves, one imbedded with OCT and snap-frozen, another fixed with 10% formalin overnight for paraffin embedding. Four-micrometer sections were cut for both frozen and paraffin-embedded kidneys. Periodic acid-Schiff staining was performed following the protocol recommended by the Animal Models of Diabetic Complications Consortium (http://www.amdcc.org). Immunostaining was conducted briefly as follows: OCT-embedded frozen sections were cut (4 m), air-dried, and incubated with blocking solution at room temperature for 30 min. Then the sections were incubated with the first antibody for 1 h at room temperature. After PBS wash for three times, second antibody was added and incubated at room temperature for 1 h. The sections were then washed, stained with DAPI, and sealed with Fluoromount-G (Southern Biotech).
Podocyte Number Counting
OCT-embedded frozen kidneys were used. Four-micrometer-thick sections were cut, and rabbit polyclonal WT1 antibody (C-19; Santa Cruz) and the second antibody goat anti-rabbit IgG (HϩL) Alex Fluor 488 (Invitrogen, Carlsbad, CA) were used to stain podocytes, followed by DAPI staining. WT1 and DAPI double-positive cells were counted as podocytes. All WT1 and DAPI double-positive cells across the whole section were counted, added up, and then divided by the total number of glomeruli on the section, resulting in the average podocyte number per glomerular cross-section.
TUNEL Assay
The apoptotic cells were detected using ApopTag Red In Situ Apoptosis Detection Kit (Chemicon Int., Temecula, CA) on frozen kidney sections. For identification of apoptotic podocytes, the kidney sections were costained with WT1 antibody and DAPI. The triple-positive cells, WT1 (green), TUNEL (red), and DAPI (blue), were considered to be apoptotic podocytes. The ones positive for WT1 and DAPI but negative for TUNEL were nonapoptotic podocytes.
Electron Microscopy
A small piece of kidney from cortex was collected, sliced into 1-mm 3 cubes, and fixed in 2% glutaraldehyde solution. The kidney samples were then processed following standard protocol.
Isolation of Glomeruli
The procedure for isolation of glomeruli was based on a published method with modifications. 58 Briefly, mice were perfused with 2.5 mg/ml iron oxide solution in PBS. Then the two kidneys from a mouse were diced into 1-mm 3 pieces. A total of 100 l of collagenase A solution (10 mg/ml) and 100 l of DNase I (1000 U/ml) were added to the tissues, and the mix was incubated at 37°C for 30 min with rotation. After passing the disrupted tissues through a 100-m cell culture strainer, several times of magnetic concentration of glomeruli were performed to obtain purified glomeruli.
Preparation of Total RNA and miRNA-Enriched Small RNA from Glomeruli Glomerular total RNA and small RNA (200 bp) fraction with miRNA enriched were prepared using mirVana miRNA isolation kit (Ambion, Austin, TX) according to the manufacturer's instructions.
Microarray
Affymetrix Genechip Mouse Genome 430 2.0 Array containing approximately 39,000 gene probes was used for gene expression profiling of the glomeruli of mutant and control mice using total RNA from purified glomeruli. The whole procedure followed the manual instruction of the product. The Affymetrix Genechip data analysis was performed using R (R-Group) and Bioconductor 59 statistics packages in combination with other widely known GeneChip analysis tools. Briefly, for preprocessing of the chip data, the raw data were normalized across the chips by log scale robust multi-array analysis (GCRMA) method, 60 which has been shown to give more accurate results than the standard algorithm supplied by Affymetrix, and the probe sets with absent calls will be eliminated for downstream analysis. For genes with multiple probe sets on the chip, the median of the expression values of duplicated probe sets was calculated to represent the expression value for corresponding genes. For identification of differentially expressed genes between two groups, the statistical package Significance Analysis of Microarrays 61 was used.
Identification of miRNA with Enriched Target Sequence in Upregulated Transcripts
To identify the potential miRNA candidates whose suppression by dicer knockout caused upregulation of their targeting genes, we used Sanger's miRNA target database (http://www.miRNA.org) to search for miRNA targeting 3Ј UTR sequences of significantly upregulated genes and the occurrence for each miRNA was obtained. For determination of the significance of miRNA occurrence, the same number of genes as miRNA targets in upregulated genes were randomly chosen from the chip gene list and the occurrence of a miRNA was counted. Such permutation steps were repeated 10,000 times. The P value was calculated as the percentage of occurrences of a miRNA for 10,000 randomly generated gene lists greater than that for upregulated genes and then adjusted by false discovery rate.
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